Inflammatory damage plays a pivotal role in ischemic stroke pathogenesis and may represent one of the therapeutic targets. Z-Guggulsterone (Z-GS), an active component derived from myrrh, has been used to treat various diseases. The traditional uses suggest that myrrh is a good candidate for anti-inflammatory damage. This study was to investigate the anti-inflammatory and neuroprotective effects of Z-GS following cerebral ischemic injury, as well as the exact mechanisms behind them. Rat middle cerebral artery occlusion (MCAO) model and in vitro astrocytes oxygen-glucose deprivation (OGD) model were adopted to simulate ischemic stroke. Z-GS (30 or 60 mg/kg) was administered intraperitoneally immediately after reperfusion, while astrocytes were maintained in 30 or 60 lM Z-GS before OGD treatment. The results indicated that Z-GS significantly alleviated neurological deficits, infarct volume and histopathological damage in vivo, and increased the astrocytes viability in vitro. Moreover, the treatment of Z-GS inhibited the astrocytes activation and down-regulated the mRNA levels of pro-inflammatory cytokines. Furthermore, the activated TLR4-NF-jB signaling pathways induced by MCAO or OGD were significantly suppressed by Z-GS treatment, which was achieved via inhibiting the phosphorylation of JNK. Our results demonstrated that Z-GS exerted neuroprotective and anti-inflammatory properties through preventing activation of TLR4-mediated pathway in the activated astrocytes after ischemia injury. Therefore, Z-GS could be considered as a promising candidate for the treatment of ischemic stroke.
Ischemic stroke is a serious and life-threatening cerebrovascular thrombotic disease (Mozaffarian et al. 2016) . It is caused by sudden interruption or complete blockage of blood flow to the brain, which initiates a complex cascade of metabolic events and eventually contributes to ischemic injury . Although the mechanism for ischemic stroke is complicated, neuroinflammation is regarded as a major contributor to stroke pathophysiology (Lakhan et al. 2009; Chen et al. 2017) . Inflammatory cells are recruited and activated when a focal cerebral ischemic stroke occurs and inhibiting the inflammatory response could promote the recovery of brain functions (Jin et al. 2010) . Increased production of proinflammatory cytokines and lower levels of the anti-inflammatory IL-10 are related to larger infarctions and poorer clinical outcome (Siniscalchi et al. 2014) . In the central nervous system (CNS), astrocytes have been linked to proinflammatory cytokines in cerebral ischemia (Hennessy et al. 2015) . Astrocytes become activated after ischemia, which leads to an inflammatory response and promotes brain injury.
Toll like receptors (TLRs) are pivotal components in the induction and regulation of immune/inflammatory responses. Among TLRs, TLR4 can exert strong regulatory effects on post-ischemic inflammatory responses by activating the transcriptional factors NF-jB (Garc ıa-Culebras et al. 2017). The activation of NF-jB can induce the excessive generation of inflammatory mediators, such as tumor necrosis factor-a (TNF-a), interleukin-1b (IL-1b) and interleukin-6 (IL-6) (Shi et al. 2017) , while the inhibition of TLR4/NF-jB inflammatory pathway can exert strong protective effects on middle cerebral artery occlusion (MCAO) rats (Belinga et al. 2016) . Therefore, the regulation of astrocytes activation and associated TLR4/NF-jB inflammatory pathway may be essential in pathological processes in the CNS and could serve as a potential therapeutic target for ischemic stroke (Wu et al. 2012) . However, the mechanisms that regulate TLR4 expression still uncertainty in ischemic stroke. According to previous evidences, LPS enhanced TLR4 expression in human aortic smooth muscle cells via JNK-mediated transcriptional pathway, and p38 may regulates post-transcriptional pathway in vascular inflammation and cardiovascular disorders (Lin et al. 2006a) . The oxidative stress from cardiopulmonary bypass technique mediated the decrease in JNK, and calpain activity may cripple the TLR4 expression in monocytes and platelets (Tsai et al. 2009 (Tsai et al. , 2014 . Recently, Tsai et al. (2016) show that eotaxin-2 induces TLR4 overexpression via JNK in human coronary artery endothelial cells (HCAECs).
Z-Guggulsterone (Z-GS) [4,17(20)-trans-pregnadiene-3,16-dione] (Fig. 1b) , asteroid derived from the resin of guggul (Commiphoramukul), has been used as an effective herbal medicine in the treatment of atherosclerosis, arthritis, hyperlipidemia, obesity, and cancer (Yamada and Sugimoto 2016) . Evidences have indicated that Z-GS possesses potential anti-inflammatory activity through inhibiting NF-jB and/or its dependent inflammatory cytokines (Lee et al. 2008; Kim et al. 2016; Zhang et al. 2016) . In addition, a recent study has found that Z-GS could attenuate lipopolysaccharide (LPS)-induced pro-inflammatory responses in microglia via blocking IjB-a-NF-jB signals ). Our present goal was to investigate a potential role for Z-GS in regulating inflammatory cascades associated with ischemia injury.
Materials and methods

Experimental animals
Adult male Sprague-Dawley rats (250-280 g, RRID: RGD_70508) were obtained from the Experimental Animal Center of Fourth Military Medical University (Xi'an, China). Rats were housed at a constant temperature (25 AE 2°C) and air humidity (50 AE 10%), with a 12 h light/dark cycle and free access to water and food. All procedures have been approved by the Animal Care and Use Committee of the Fourth Military Medical University in compliance with the NIH Guide for the Care and Use of Laboratory Animals (NIH Publications No. 8023, revised 1978) and the ARRIVE2009 Guidelines for Reporting Animal Research (Kilkenny et al. 2010) . For the sample size calculation, preliminary experiment indicated that there was at least 10% difference in infarct volume between groups with standard deviation associated with these measurements to be 0.06. Therefore, we required a minimum of six animals per group to detect such a difference at 95% confidence (a = 0.05) and 0.8 power. The study was not pre-registered prior to examination of the data or observing the outcomes.
Acute toxicity study Acute oral toxicity study was performed as per Organization for Economic Cooperation and Development (OECD) guidelines 425 (OECD, 2001) . The rats were starved overnight and divided into five groups (n = 6) by using a table of random numbers. Z-GS was orally fed in increasing dose levels of 100, 200, 400, 800 and 1600 mg/kg. The rats were observed individually at least once during the first 30 min, periodically during the first 24 h, with special attention given during the first 4 h, and daily thereafter, they were observed for a total of 14 days for any physical signs of toxicity such as writhing, gasping, palpitation and decreased respiratory rate or mortality. After 14 days, the lethality or death was calculated. The results demonstrated that Z-GS did not show any sign of toxicity or abnormal symptom in the rats of dosing up to 1600 mg/kg. There was also no mortality observed up to 2 weeks. Therefore, it is concluded that Z-GS at a lower dosage of 30 and 60 mg/kg is safe to be fed to rats.
MCAO model and drug administration
The rats were identified by earmarks and numbered accordingly. Using a table of random numbers animals were randomly divided into the following four groups: sham operation group (Sham), MCAO model group (MCAO), low dosage Z-GS treatment group (Z-GS-L) and high dosage Z-GS treatment group (Z-GS-H). All the experiments were performed in the following order: MCAO, Z-GS-L, Z-GS-H, Sham. A standard model of MCAO was performed as previously described (Cao et al. 2014) . Briefly, rats were anesthetized with 5% isoflurane and maintained with 0.5% isoflurane during surgery (both in 30% oxygen/70% nitrous oxide). The right side of common carotid artery, external carotid artery and inner carotid artery were exposed and isolated. Middle cerebral artery (MCA) was occluded by inserting a 4-0 monofilament nylon suture (Doccol, MA, USA) from external carotid artery to inner carotid artery. The filament was slowly withdrawn 2 h after the induction of ischemia. Animals in the sham group were manipulated in the same way except the monofilament insertion. Z-GS (purity ≥ 98%, Santa Cruz, CA, USA, Catalogue numbers: sc-204414A) were dissolved in Dimethyl sulfoxide (DMSO) and stored at À20°C, final The neurologic score of rats after 3 days reperfusion (n = 8). TTC staining (d, Scale bar = 1 cm) and infarct volume (e) were performed at 3 days after reperfusion. The H&E (f) and TUNEL staining (g) of brain tissue (Scale bar = 50 lm). Data were presented as the mean AE SD (n = 6 rats) except for the neurologic score. concentration of DMSO is < 5% (the concentration was adjusted with normal saline). 30 mg/kg Z-GS (Z-GS-L group) and 60 mg/kg Z-GS (Z-GS-H group) were administrated intraperitoneally daily for 3 days immediately after the onset of reperfusion. The Z-GS dosage was selected based on the previously studies Huang et al. 2016) . Rats in sham and MCAO group were injected with 5% DMSO/saline solution as vehicle control. The time-line diagram of animal experiments was showed in Fig. 1a . There was no sample size difference between the beginning and end of the experiments.
Neurological examination and infarct assessment Neurological deficits were evaluated by an experimenter who was blinded to the group information at 3 days after the MCAO procedure with a 5-point scale system reported previously (Longa et al. 1989; Wang et al. 2016) . The neurological scores were defined as follows: 0, no neurological dysfunction; 1, failure to extend left forelimb fully; 2, circling to the contralateral side; 3, falling to the left side; 4, no spontaneous locomotor activity.
Infarct volume was assessed by 2, 3, 5-triphenyltetrazolium chloride (TTC, Sigma-Aldrich, St. Louis, MO, USA) staining method. Rats were deeply anesthetized with 40 mg/kg sodium pentobarbital before they were executed, and the brains were quickly removed. The brains were cut into 2-mm coronal sections and immersed in 2% TTC at 37°C for 20 min, and then fixed with 10% paraformaldehyde. After staining, the color of the infarct area was white while non-ischemic area was red. Total infarct volume was measured using image analysis software (Adobe Photoshop CS6, Adobe Systems Incorporated, San Jose, CA, USA). Edema correction of infarct volume was calculated by the following equation: Vedi=Vinfarct9 (1À(VipsiÀVcontra)/Vcontra); Vedi, volume edema corrected infarct; Vinfarct, volume infarct; Vipsi, volume ipsilateral hemisphere; Vcontra, volume contralateral hemisphere.
H&E and TUNEL staining
After anesthesia, rats were perfused with physiological saline and 4% paraformaldehyde. The brains were removed and fixed with 4% paraformaldehyde for 24 h. The brain tissue was embedded in paraffin and then cut into sections (5 lm thickness). The sections were stained with hematoxylin and eosin (H&E) for histopathological observation. TUNEL staining was performed to detect the apoptosis level with a commercially available kit (Beyotime Institute of Biotechnology Co., Ltd Haimen, China). The total number of TUNEL positive cells was counted in five different fields for each section by an investigator who was blinded to the studies.
Immunofluorescent and immunohistochemistry staining
Frozen sections were acquired immediately after the brains were removed. The sections were blocked with 1% bovine serum albumin for 1 h at 20-25°C, and then were incubated with primary antibodies overnight at 4°C: anti-glial fibrillary acidic protein (GFAP) antibody (1 : 100, CST, Catalogue numbers: sc-33673, RRID: AB_627673), anti-TLR4 antibody (1 : 200, Abcam (Cambridge, UK), Catalogue numbers: ab-13867, RRID: AB_300696) and anti-phosphorylated-P65 (p-P65(ser536)) antibody (1 : 200, CST, Catalogue numbers: sc-136548, RRID: AB_10610391). After washing in phosphate buffer saline, the samples were incubated with appropriate secondary antibodies for 1 h in 20-25°C. The nuclear layers were visualized with DAPI (Santa Cruz, CA, USA). The stained sections were imaged with confocal microscope (Nicon, Japan). Quantification of doublelabeled cells was performed by researchers who were blinded to the group information. For immunohistochemistry analysis, a standard staining operation was performed in paraffin-embedded sections with anti-phosphorylated-JNK (p-JNK) antibody (1 : 200, Abcam) and anti-TNF-a antibody (1 : 200, Abcam). The levels of immunoreactivity were calculated by Image Pro Plus 6.0 image analysis software in a blinded manner.
Primary astrocyte cultures
Primary cultures of astrocytes were obtained and purified from 1-day-old Sprague-Dawley rats as previously described (Xu et al. 2016 ) with minor modifications. Briefly, the cerebral cortices were isolated, and minced by mechanical trituration in 0.125% Trypsin-EDTA solution. After the tissue fragments were filtered, dissociated cells were centrifuged and resuspended in high glucose Dulbecco's Modified Eagle Medium (Invitrogen, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum and 1% penicillin-streptomycin. Then the cells were seeded on 75-cm 2 culture flasks coated with ploy-L-lysine (50 lg/mL; Sigma-Aldrich) and cultured in an incubator containing 5% CO 2 at 37°C for 7-9 days when they reached confluence. The flasks were placed in an orbital shaker at 300 rpm for 4-6 h to remove microglia and oligodendrocytes from the astrocyte monolayer. The remaining cells were gently trypsinized and transferred into small wells and were then incubated for at least 24 h before further experiments. Purity of astrocytes cell was assessed by immunofluorescence staining. The percent of GFAPpositive cells was over 95% were identified as astrocytes.
Oxygen-glucose deprivation Astrocytes were exposed to transient oxygen-glucose deprivation (OGD) to model ischemia-like conditions. Briefly, the feeding media was replaced with glucose-free medium and the cultures were incubated in a tri-gas incubator (Thermo Scientific, MA, USA) with 1% O 2 for 6 h with or without Z-GS (30 or 60 lM). Z-GS was dissolved in DMSO and final concentration of DMSO is < 0.1%. Astrocytes in control or OGD group received the same dosage of DMSO as blank control. After that, the astrocytes were incubated again in the normoxic incubator with normal culture medium for an additional 24 h for reperfusion.
Cell viability and apoptosis assay Cell viability was determined at 24 h post-OGD by two widely accepted assays, MTT assay and lactate dehydrogenase (LDH) release assay. The experiments were conducted according to the manufacturer's protocol of a cell cytotoxicity assay kit and a lacatedehydrogenase assay kit (Jiancheng Biotechnology, Nanjing, China). An Annexin V-FITC/PI Apoptosis Detection Kit (7Sea Pharmatech Co., Ltd, China) was used to perform apoptosis of astrocytes according to the manufacturer's instructions. Apoptotic changes were detected by an Accuri C6 Plus flow cytometry (BD, USA).
Western blotting analysis
The total proteins were extracted from the brain tissues or cells and the concentration were measured by bicinchoninic acid protein assay kit (Beyotime, Shanghai, China). Quantitative RT-PCR Total RNA in the samples was isolated using Trizol Reagent (Pufei, Shanghai, China) according to the manufacture's protocol. Quality of RNA was examined and all has reached the request of PCR. About 2 lg total RNA was processed for cDNA synthesis by using a cDNA first-strand synthesis system (Ferment as International Inc, Burlington, Canada). Amplification and detection were performed with the ABI 7500 Real Time PCR system (Applied Biosystems, Foster City, CA, USA). The PCR amplification conditions were as follows: 94°C for 45 s and 55°C for 45 s to denaturation, and at 72°C for 45 s for 50 cycles to extension. All the assays were performed in triplicate. Transcript levels were quantified by using the 2 ÀDDCT method and were normalized to b-actin. The sequences of the primers used in this study are listed in Additional file (Table S1 ).
Statistics analysis
Statistical analysis was carried out with SPSS version 19.0 (SPSS Inc., Chicago, IL, USA). The normality of data was assessed with Shapiro-Wilk test firstly. Normally distributed data were presented as mean AE SD. Statistical differences between the various groups were analyzed by one-way ANOVA followed by the SNK-q test. Neurobehavioral scores were assessed as non-normally distributed variables, so the data were presented as the median (interquartile range, IQR) and were analyzed by the Mann-Whitney U test. In all cases, p < 0.05 was considered statistical significance.
Results
Z-GS improved the neurological outcome and reduced the infarct volume in MCAO rats
The rats were scored for neurologic deficit after reperfusion. Neurological scores were significantly increased in MCAO group compared to the sham group. Administration of Z-GS remarkably improved the neurological outcomes of MCAO rats (Fig. 1c) . To evaluate infarct volume, sections of brain tissue were stained with TTC. No injured area was found in the sham operated control group. In contrast, an extensive lesion in brain tissue was found in the model of MCAO (Fig. 1d) . The results of image analysis showed that Z-GS treatment greatly reduced volume of cerebral infarction compared with the MCAO model group (Fig. 1e) . In addition, high dosage of Z-GS (60 mg/kg) had a greater effect on neurological outcome and infarction volume than a low dose of Z-GS (30 mg/kg) did.
Z-GS attenuated MCAO-induced brain injury and apoptosis
Histopathological changes were investigated by using H&E staining. After ischemia, disordered neurons arrangement, neuronal loss and karyopyknosis were demonstrated. Treatment with Z-GS could ameliorate histopathological damages, and the high dosage group exhibited fewer pathological changes (Fig. 1f) . In order to examine whether Z-GS could suppress neuronal apoptosis in MCAO brain, TUNEL staining was performed to quantify apoptotic cells. The results indicated the presence of massive TUNEL positive staining cells in the ischemic area. Z-GS treatment significantly decreased the density of TUNEL positive cells, especially of high dosage (Fig. 1g ).
Z-GS suppressed apoptosis in OGD-injured astrocytes
Next, flow cytometry with Annexin V-FITC/PI staining was performed to quantify the OGD-induced apoptosis in vitro.
As shown in Fig. 2(a) , the apoptotic ratio was significantly increased in OGD group, while it was markedly decreased in the Z-GS group. Moreover, 60 lM Z-GS showed a better protective effect than 30 lM Z-GS did (Fig. 2b) . The results indicated that Z-GS effectively reduced the OGD-induced apoptosis in astrocytes in vitro. The cell viability of primary astrocytes was evaluated by MTT and LDH release assay at 24 h after OGD stimulation, respectively, in the absence and presence of Z-GS treatment. The data revealed that the cell viability was significantly decreased and the LDH release was greatly increased in OGD-insulted astrocytes compared with the control group ( Fig. 2c and d) . Z-GS increased the MTT value and reduced cell LDH release compared with the condition of vehicle treatment on OGD6 h/R24 h. Meanwhile, higher viability was found in the high-dosage group compared with low-dosage group.
Z-GS inhibited GFAP expression in MCAO rats and OGD-injured astrocytes
The activation of astrocytes is associated with cerebral ischemia (Ashafaq et al. 2016) . GFAP, a typical marker for astrocytes, was found to be remarkably up-regulated in ischemic brain and OGD-induced astrocytes. In comparison to model group, a noticeable reduction in GFAP expression was observed in Z-GS treated groups, which suggested that Z-GS inhibited the activation of astrocytes after ischemia (Fig. 3) .
Z-GS decreased brain pro-inflammatory cytokines mRNA levels in ischemic brain
Astrocytes participate in inflammatory and degenerative processes by secreting cytokines. The most studied cytokines related to inflammation in acute ischemic stroke are TNF-a, IL-1b, IL-6, interferon-c (IFN-c) and monocyte chemotactic protein-1 (MCP-1) (Planas and Chamorro 2009 ). Thus, we investigated the effects of Z-GS on the release of pro-inflammatory cytokines in ischemic brain at day 3 after MCAO. In the results, the mRNA expressions of TNF-a, IL-1b, IL-6, IFN-c and MCP-1 were increased significantly in MCAO group. As expected, Z-GS treatment greatly reversed the changes (Fig. 4a-e) . The protein expression of TNF-a in ischemic brain was also detected by immunohistochemistry. The result was consistent with the qPCR findings (Fig. S1 ).
Z-GS decreased pro-inflammatory cytokines mRNA levels in astrocytes
To further confirm the anti-inflammatory effect of Z-GS on OGD-induced astrocytes, inflammatory cytokines, including IL-1b, TNF-a, IL-6, MCP-1 and IFN-c were detected by quantitative real-time RT-PCR. Pro-inflammatory cytokines were found dramatically increased after OGD, but they were obviously reduced under Z-GS treatment (Fig. 4f-j) .
Z-GS increased anti-inflammatory cytokines mRNA levels in ischemic brain
Both the pro-inflammatory and anti-inflammatory cytokines are key players in the inflammatory mechanisms and contribute to the progression of ischemic damage. Thus, we detected the mRNA level of IL-10 and TGF-b1, two typical anti-inflammatory cytokines, in ischemic brain by qPCR. The results showed that a slightly but not significantly increase in the anti-inflammatory cytokines at 72 h after MCAO. Compared to the MCAO group, IL-10 and TGF-b1 were found dramatically elevated after Z-GS treatment. The findings indicated that Z-GS attenuated neuroinflammation after ischemia through inhibiting the pro-inflammatory cytokines while increasing the anti-inflammatory cytokines (Fig. S2 ).
Z-GS decreased the activation of TLR4-NF-jB pathway in OGD-stimulated astrocytes TLR4 activation induced NF-jB to generate the release of inflammatory cytokines such as IL-1, IL-6, etc. To better understand the neuroprotective mechanism offered by Z-GS, we investigated activation of TLR4-NF-jB pathway in vitro. TLR4 protein expression was significantly increased under OGD treatment. Phosphorylation of IjB proteins by IKK complex was essential for NF-jB activation. Upon a variety of stimuli, IKK complex led to phosphorylation of p65 at Ser536, thereby enhance p65 transactivation potential (Viatour et al. 2005) .The expression of p-IjBa, p-P65(ser536), and n-P65 levels in the OGD group was also dramatically increased compared with the control group. The Z-GS (c) Western blot analysis for the protein level of GFAP in primary cultures of astrocytes. Data were presented as the mean AE SD (n = 6 rats or cell samples), ## p < 0.01 versus sham (or control) group; *p < 0.05, **p < 0.01 versus middle cerebral artery occlusion (MCAO) (or OGD) group treatment hindered the OGD-induced elevation of TLR4, pIjBa, p-P65(ser536), and n-P65. Meanwhile, no difference of total P65 was found between each group (Fig. 5) .
Z-GS suppressed the activation of TLR4-NF-jB pathway in ischemic brain TLR4 and p-P65(Ser536) expression was increased markedly after MCAO injury in parietal cortex of rats shown by immunofluorescence (Fig. 6) . Though the TLR4 and p-P65 (Ser536) levels in the MCAO group were higher than the sham group, they were significantly less in Z-GS treated groups. In addition, colocalization of either TLR4 or p-P65 (ser536) with GFAP was markedly increased in the MCAO group. These expression changes after MCAO injury were consistent with the inflammation responses and cell apoptosis in ischemic brain of rats.
Z-GS suppressed TLR4 expression via inhibiting the phosphorylation of JNK in MCAO rats and OGD-injured astrocytes JNK was involved in regulating TLR4 expression. Evidence showed that GS attenuated pancreatitis via inhibition of JNK Fig. 4 Effect of Z-GS on the release of pro-inflammatory cytokines. Quantitative RT-PCR was performed to detect the mRNA levels of inflammatory cytokines (including IL-1b, IL-6, TNF-a, IFN-c and MCP-1) in ischemic brain (a-e) and oxygen-glucose deprivation (OGD)-induced astrocytes (f-j). Data were shown as mean AE SD (n = 6), ## p < 0.01 versus sham/control group; *p < 0.05, **p < 0.01 versus middle cerebral artery occlusion (MCAO)/OGD group. Fig. 5 Effect of Z-GS on the activation of TLR4-NF-jB pathway in oxygen-glucose deprivation (OGD)-induced astrocytes. The primary cultures of astrocytes were exposed to transient OGD after Z-GS treatment. The protein levels of TLR4, phospho-P65 (p-P65 (ser536)), phospho-IjBa (p-IjBa), total-P65 (t-P65), total-IjBa (t-IjBa), and nuclear-P65 (n-P65) were investigated by western blot. Data were presented as mean AE SD for 3 independent experiments. ## p < 0.01 versus control group; *p < 0.05, **p < 0.01 versus OGD group. activation (Kim et al. 2015; Tsai et al. 2016) . Therefore, we here explored the effect of Z-GS on JNK activation in MCAO rats and OGD-injured astrocytes. As shown in Fig. 7a , the phosphorylation of JNK was greatly upregulated in MCAO rats. Z-GS significantly suppressed the activation of JNK at concentrations of 30 and 60 mg/kg. In addition, we observed that the p-JNK level was also markedly elevated after OGD stimulation in primary cultured astrocytes. Pre-incubation with Z-GS in OGD-induced astrocytes inhibited phosphorylation of JNK at concentrations of 60 lM (Fig. 7c and d) .
Discussion
Ischemic stroke is the most common form of stroke with high mortality and disability. After the onset of ischemia, the brain cells suffer depletion of energy supply, excessive accumulation of intracellular calcium, overproduction of free radicals, and potentiation of inflammatory responses (Li et al. 2015a; Hoque et al. 2016) . These events initiate a complex sequence of signaling cascades that eventually result in neuronal dysfunction and cell death by necrosis or apoptosis (Radak et al. 2017) . In this study, Z-GS remarkably improved the neurological outcome and decreased the infarct volume compared with the MCAO group. The neuroprotective effect of Z-GS was further validated by H&E and TUNEL staining (Fig. 1) . Moreover, OGD treated astrocytes were used to mimic cerebral ischemia in vitro (Xu et al. 2014) . The viability of astrocytes was greatly decreased under OGD condition and increased after Z-GS treatment (Fig. 2) . The significant neuroprotective effects of Z-GS warranted our further study on the underlying mechanisms.
Astrocytes are the most abundant cells in the CNS and play multiple roles in the brain, such as providing nutrients, modulating synaptic function and maintaining homeostasis (Pekny and Pekna 2014) . In addition, astrocytes contribute to regulation of the neuroinflammation, being responsible for CNS immunity as immunocompetent cells (Guizzetti et al. 2014) . When cerebral ischemia occurs, astrocytes become activated and lead to an inflammatory response by secreting diverse pro-inflammatory cytokines such as IL-1b, IL-6, TNF-a, IFN-c and MCP-1. And the expression of GFAP, one of the prototypical markers for identification of astrocytes, increases in reactive astrocytes (Sofroniew and Vinters 2010) . Sustained activation of pro-inflammatory cytokines as well as enhanced expression of GFAP, are known to aggravate brain damage (Hennessy et al. 2015) , while the inhibition of these cytokines and activated astrocytes is beneficial to the therapy of ischemic stroke (Ashafaq et al. 2016; Pan et al. 2017) . It was also reported that OGD induced the secretion of pro-inflammatory cytokines and the activation of astrocytes in vitro (Li et al. 2015b; Xia et al. 2017) . As shown here, the immunoreactivity of GFAP protein was increased in brain after MCAO and in astrocytes after OGD, and it was markedly inhibited after Z-GS treatment (Fig. 3) . Additionally, the production of proinflammatory cytokines in astrocytes induced by MCAO or OGD were also significantly suppressed by Z-GS treatment (Fig. 4) . These results indicated that Z-GS suppressed the activation and the excessive inflammatory responses of astrocytes, therefore prevented inflammation in acute ischemic stroke.
Since TLRs were identified as essential components of the innate immune system, they have been the subject of intensive investigation on their role in the inflammatory process (Lehnardt et al. 2003) . Studies have shown that TLR4 in astrocytes plays vital role in the pathogenesis of ischemic damage (Bowman et al. 2003; Skvortsova et al. 2011) , and TLR4-deficient mice have minor infractions and less inflammatory response after MCAO (Caso et al. 2007) . To better understand the neuroprotective mechanism offered by Z-GS, we looked at the expression of TLR4. Z-GS treatment showed lower level of TLR4 compared with vehicle both in vivo and in vitro (Figs 5 and 6 ). In response to ischemic stimulation, TLR4 activates several downstream signal pathways, and mainly initiates the activation of NF-jB in the end (Zhou et al. 2015) . It is well established that NF-jB is activated during MCAOinduced ischemic injury. Reducing its activity is associated with reduction in infarct volume after MCAO (Wang et al. 2009 ). Activation of NF-jB mainly occurs via IjB kinase (IKK)-mediated phosphorylation of inhibitory molecules, including IjBa. Optimal induction of NF-jB target genes also requires phosphorylation of NF-jB proteins, such as p65 (Ridder and Schwaninger 2009) . Numerous studies have reported the ability of various kinases to phosphorylate p65 in response to distinct stimuli. In most cases, phosphorylaiton of P65 at Ser536 enhance its transactivation potential. Upon stimulation by TNFa or Kaposi's sarcoma-associated herpesvirus K15 protein, activation of the IKK complex leads to phosphorylation of p65 at Ser536 (Sakurai et al. 1999; Havemeier et al. 2014) . Thus, we detected P65 phosphorylation in ipsilateral brain. Z-GS treatment showed significantly lower level of phosphorylated P65(Ser536) when compared to vehicle treatment both in vitro and in vivo (Figs 5 and 6) and did not have any effect on basal expression of total P65. Therefore, the results suggested that Z-GS exerted its anti-inflammatory effect through interfering with the TLR4-NF-jB pathways in astrocytes.
Even though the TLR4-mediated signaling pathway may contribute to inflammation including ischemic stroke, the underlying mechanisms involved in regulation of TLR4 expression are still confusion and remain to be explored. TLR4 mRNAs contain AU-rich elements in their 3 0 untranslated regions (3 0 UTR) which have a high affinity for RNA-binding proteins, such as human antigen R (HuR) (Kracht and Saklatvala 2002) . LPS markedly increases cytosolic HuR level in human aortic smooth muscle cells and enhances the interaction of HuR and 3 0 UTR of TLR4 mRNA. And that HuR modulates 3 0 UTR-mediated TLR4 mRNA expression. In addition, a decrease in p38 MAPK activity by SB203580 significantly decreased the cytosolic HuR level, which mediates TLR4 mRNA stability (Lin et al. 2006b ). However, the study also suggests that LPS-induced TLR4 mRNA expression was reduced by SP600125 (a JNK inhibitor) but not by SB203580 (a p38 MAPK inhibitor). LPS-induced TLR4 protein expression was significantly reduced by SB203580 and SP600125 suggesting that JNK play more significant roles than that of p38 MAPK in the transcriptional regulatory signaling pathway (Lin et al. 2006a) . Recently, it has been demonstrated that Lysosomeassociated small Rab GTPase Rab7b negatively regulates TLR4 signaling in macrophages by promoting lysosomal degradation of TLR4 (Wang et al. 2007) . Therefore, the transcription signaling pathways, post-transcriptional modification and lysosomal degradation may modulate expression of TLR4. We here showed that Z-GS greatly inhibited activation of JNK in MCAO rats and OGD treated astrocytes, which could partially explain the Z-GS-mediated decrease in TLR4 in ischemic stroke (Fig. 7) . The data suggested that the activation of JNK may account for the increased expression of TLR4 in cerebral ischemia. Although these results provided a basis for further controlling TLR4 expression as therapeutic strategy in restraining inflammation in ischemic stroke, the detailed underlying mechanisms of TLR4 expression remain to be studied continuously in the future. In addition, we mainly focused on the acute stage of ischemia in this study, the long-term therapeutic effects of Z-GS in poststroke need to be conducted in further researches.
Taken together, these data suggested that Z-GS protect against brain ischemia by blunting the activation of astrocytes and reducing inflammation through inhibiting TLR4-mediated pathway. Therefore, people who are prone to stroke or who have suffered stroke may potentially benefit from pretreatment with Z-GS.
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